In this ClubTest deep dive, we assess the Callaway Elyte driver line, which our testers admired for its ...

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

What is not dramatic is the hypothesized slow probe needle or contactor degradation process that might precede catastrophic ...